Genotoxic impurities

22
Genotoxic Impurities (Dr). Santosh Kumar Narla, Formulation Regulatory Affairs, [email protected]

description

Genotoxic Impurities, Background, Controlling of genotoxic impurities.

Transcript of Genotoxic impurities

Page 1: Genotoxic impurities

Genotoxic Impurities(Dr). Santosh Kumar Narla,

Formulation Regulatory Affairs,[email protected]

Page 2: Genotoxic impurities

Genotoxic impurities

Impurities are unwanted chemicals, have no therapeutic value and are potentially harmful. Therefore they need to be controlled in API and DP.

Impurities can be classified into:

Organic impurities (process- and drug-related)

Inorganic impurities

Residual solvents

Genotoxic impurities

Sources of impurities:

Starting materials

By-products

Intermediates

Degradation products

Reagents, ligands and catalysts

Page 3: Genotoxic impurities

Evidence of genotoxicity:

Genetic damage,

Cell death

neoplastic transformation.

Regulatory Expectations:

• January 2007

EMEA CHMP Guideline on the Limits of Genotoxic Impurities

• February 2008

EMEA letter requesting evaluation of sulfonic esters in all marketed products

• June 2008 and December 2009

EMEA Questions & Answers Documents on the CHMP Guideline on the Limits of

Genotoxic Impurities

• December 2008

FDA Draft Guidance for Industry: Genotoxic and Carcinogenic Impurities in Drug

Substances and Products; Recommended Approaches

Page 4: Genotoxic impurities

Genotoxic potential “alert structures”

Page 5: Genotoxic impurities

Genotoxins: EMEA/CHMP/QWP/251344/2006

•Are considered unsafe at any level.

•A limit for a genotoxin with an understood toxicity can be calculated based

upon the known PDE.

•A limit for a genotoxin without sufficient toxicity information must determine

based upon a TTC of 1.5 ug/day.

Max limit = TTC/maximum dose.

•Levels above this limit need to justified toxicologically.

•Limits for genotoxins like aflatoxins, N-nitroso-, and azoxy-compounds are

considered so toxic they must be justified using toxicological study data.

TTC = Threshold of Toxological Concern

Page 6: Genotoxic impurities

ADI and Daily Dose

“A Rationale for Determining, Testing and Controlling Specific Impurities in Pharmaceuticals that Possess Potential for Genotoxicity”, Mueller, et al., Regulatory Toxicology and Pharmacology44(2006) 188-211.

Page 7: Genotoxic impurities

Categorization, Qualification and Risk Assessment

Page 8: Genotoxic impurities
Page 9: Genotoxic impurities
Page 10: Genotoxic impurities
Page 11: Genotoxic impurities

Relationship Between Staged TTC, Drug Dose and Impurity Concentration Limit

Page 12: Genotoxic impurities

Assessment of Potential Genotoxic Impurities

Page 13: Genotoxic impurities
Page 14: Genotoxic impurities
Page 15: Genotoxic impurities
Page 16: Genotoxic impurities
Page 17: Genotoxic impurities
Page 18: Genotoxic impurities
Page 19: Genotoxic impurities

Decision Tree

Page 20: Genotoxic impurities
Page 21: Genotoxic impurities
Page 22: Genotoxic impurities